207 related articles for article (PubMed ID: 33731151)
21. Lymphangioleiomyomatosis.
Doubková M; Štefániková M; Čan V; Merta Z; Svoboda M
Klin Onkol; 2019; 32(5):367-374. PubMed ID: 31610670
[TBL] [Abstract][Full Text] [Related]
22. Renal angiomyolipoma in association with pulmonary lymphangioleiomyomatosis.
De Pauw RA; Boelaert JR; Haenebalcke CW; Matthys EG; Schurgers MS; De Vriese AS
Am J Kidney Dis; 2003 Apr; 41(4):877-83. PubMed ID: 12666075
[TBL] [Abstract][Full Text] [Related]
23. Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus.
Taveira-DaSilva AM; Hathaway O; Stylianou M; Moss J
Ann Intern Med; 2011 Jun; 154(12):797-805, W-292-3. PubMed ID: 21690594
[TBL] [Abstract][Full Text] [Related]
24. Angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis.
Bissler JJ; Nonomura N; Budde K; Zonnenberg BA; Fischereder M; Voi M; Louveau AL; Herbst F; Bebin EM; Curatolo P; Zonta A; Belousova E
PLoS One; 2018; 13(9):e0201005. PubMed ID: 30192751
[TBL] [Abstract][Full Text] [Related]
25. Coexistence of pulmonary lymphangioleiomyomatosis and pulmonary angiomyolipoma.
Sun X; Feng R; Zhang Y; Shi J; Xu KF
BMC Pulm Med; 2016 Aug; 16(1):120. PubMed ID: 27527652
[TBL] [Abstract][Full Text] [Related]
26. Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations.
Freitas CS; Baldi BG; Araújo MS; Heiden GI; Kairalla RA; Carvalho CR
J Bras Pneumol; 2015; 41(3):275-80. PubMed ID: 26176526
[TBL] [Abstract][Full Text] [Related]
27. Clinical features of lymphangioleiomyomatosis complicated by renal angiomyolipomas.
Mizushina Y; Bando M; Hosono T; Mato N; Nakaya T; Ishii Y; Yamasawa H; Sugiyama Y
Intern Med; 2011; 50(4):285-9. PubMed ID: 21325759
[TBL] [Abstract][Full Text] [Related]
28. Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study.
Zhan Y; Shen L; Xu W; Wu X; Zhang W; Wang J; Li X; Yang Y; Tian X; Xu KF
Orphanet J Rare Dis; 2018 Feb; 13(1):34. PubMed ID: 29458386
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of sirolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: a systematic review.
Peng ZF; Yang L; Wang TT; Han P; Liu ZH; Wei Q
J Urol; 2014 Nov; 192(5):1424-30. PubMed ID: 24813310
[TBL] [Abstract][Full Text] [Related]
30. [Case of tuberous sclerosis complex with pulmonary lymphangioleiomyomatosis and angiomyolipomas of the liver and kidney].
Ishitobi F; Fukuma A; Shibata H; Nagai A
Rinsho Byori; 2011 Jun; 59(6):571-6. PubMed ID: 21815479
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of transbronchial lung biopsy for the diagnosis of lymphangioleiomyomatosis: A report of 24 consecutive patients.
Koba T; Arai T; Kitaichi M; Kasai T; Hirose M; Tachibana K; Sugimoto C; Akira M; Hayashi S; Inoue Y
Respirology; 2018 Mar; 23(3):331-338. PubMed ID: 28960664
[TBL] [Abstract][Full Text] [Related]
32. Serum vascular endothelial growth factor-D as a diagnostic and therapeutic biomarker for lymphangioleiomyomatosis.
Hirose M; Matsumuro A; Arai T; Sugimoto C; Akira M; Kitaichi M; Young LR; McCormack FX; Inoue Y
PLoS One; 2019; 14(2):e0212776. PubMed ID: 30818375
[TBL] [Abstract][Full Text] [Related]
33. Spontaneous pneumothoraces during pregnancy in patients with lymphangioleiomyomatosis.
Munshi A; Hyslop AD; Kopras EJ; Gupta N
Respir Investig; 2023 Sep; 61(5):632-635. PubMed ID: 37451227
[TBL] [Abstract][Full Text] [Related]
34. Lymphangioleiomyomatosis: differential diagnosis and optimal management.
Xu KF; Lo BH
Ther Clin Risk Manag; 2014; 10():691-700. PubMed ID: 25187723
[TBL] [Abstract][Full Text] [Related]
35. Durability of Sirolimus for Lymphangioleiomyomatosis.
Martirossian A; Shah S; Carrete L; Valle J; Valentine V
Am J Med Sci; 2017 Dec; 354(6):603-607. PubMed ID: 29208258
[TBL] [Abstract][Full Text] [Related]
36. Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis.
Logginidou H; Ao X; Russo I; Henske EP
Chest; 2000 Jan; 117(1):25-30. PubMed ID: 10631194
[TBL] [Abstract][Full Text] [Related]
37. Current management of lymphangioleiomyomatosis.
Taillé C; Borie R; Crestani B
Curr Opin Pulm Med; 2011 Sep; 17(5):374-8. PubMed ID: 21760507
[TBL] [Abstract][Full Text] [Related]
38. Sirolimus reduces the risk of pneumothorax recurrence in patients with lymphangioleiomyomatosis: a historical prospective self-controlled study.
Cheng C; Xu W; Wang Y; Zhang T; Yang L; Zhou W; Hu D; Yang Y; Tian X; Xu KF
Orphanet J Rare Dis; 2022 Jul; 17(1):257. PubMed ID: 35804431
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in the pathobiology and clinical management of lymphangioleiomyomatosis.
Harari S; Spagnolo P; Cocconcelli E; Luisi F; Cottin V
Curr Opin Pulm Med; 2018 Sep; 24(5):469-476. PubMed ID: 29927757
[TBL] [Abstract][Full Text] [Related]
40. Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial.
Bissler JJ; Kingswood JC; Radzikowska E; Zonnenberg BA; Frost M; Belousova E; Sauter M; Nonomura N; Brakemeier S; de Vries PJ; Berkowitz N; Miao S; Segal S; Peyrard S; Budde K
Nephrol Dial Transplant; 2016 Jan; 31(1):111-9. PubMed ID: 26156073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
